Trials / Terminated
TerminatedNCT00326196
Coronary Artery Revascularization in Diabetes
CSP #557 - Coronary Artery Revascularization in Diabetes (VA CARDS)
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 198 (actual)
- Sponsor
- US Department of Veterans Affairs · Federal
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, multi-site, clinical trial comparing percutaneous coronary stenting (PCI) with drug eluding stents to coronary bypass for angiographically significant coronary artery disease in diabetes. The hypothesis being tested is that a strategy of surgical revascularization is superior to percutaneous intervention in preventing death or myocardial infarction in diabetics with severe ischemic heart disease.
Detailed description
Diabetic patients (HbA1c greater than 6.0% if treated or greater than 6.9% untreated) with severe ischemic heart disease and clinical indications for coronary revascularization will be screened and, if agreeable, entered into the study. Qualified patients unwilling to participate in the randomized trial will be approached for participation in a Registry that will collect computerized health data. The study consists of a 4-year accrual period. The median follow-up will be 3.7 years with a maximum of six years and a minimum of two years. Six sites will begin recruitment in the first year followed by nine additional sites for the remaining three years. The study is powered to detect a 40% relative difference between the groups in time to death or MI with a two-sided, type I error of 5% and a power of 90%.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Percutaneous coronary intervention (PCI) | percutaneous coronary stenting with drug eluding stents |
| PROCEDURE | Coronary artery bypass graft (CABG) | coronary bypass |
Timeline
- Start date
- 2006-07-01
- Primary completion
- 2012-08-01
- Completion
- 2012-08-01
- First posted
- 2006-05-16
- Last updated
- 2014-04-25
- Results posted
- 2014-02-06
Locations
26 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00326196. Inclusion in this directory is not an endorsement.